Kakkis Emil D Insider Trades

Insider Trading History

Track insider trading activity for Kakkis Emil D. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $21.2M 735,739 shares
Last Trade
Apr 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.88M 76,745 shares
$24.52
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $3.82M 132,693 shares
Last Trade
Apr 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.25M 132,693 shares
$24.52
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $19M 658,994 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.24M 54,404 shares
$22.80
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $20.5M 712,908 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66M 71,177 shares
$23.39
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $18.5M 641,731 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.09M 73,434 shares
$42.10
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $20.6M 715,165 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.37M 78,448 shares
$42.92
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $62.1M 2,158,985 shares
Last Trade
Feb 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.06M 25,000 shares
$42.48
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $62.8M 2,183,985 shares
Last Trade
Dec 30, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$495k 11,727 shares
$42.23
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $63.1M 2,195,712 shares
Last Trade
Dec 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$414k 8,273 shares
$50.00
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $63.4M 2,203,985 shares
Last Trade
Dec 09, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$986k 20,000 shares
$49.32
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $64M 2,223,985 shares
Last Trade
Sep 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.12M 20,000 shares
$55.85
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $64.5M 2,243,985 shares
Last Trade
Aug 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1M 20,000 shares
$50.17
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $16.1M 560,781 shares
Last Trade
Mar 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$935k 17,417 shares
$53.69
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $16.6M 578,198 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.76M 70,094 shares
$53.69
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $15.5M 539,770 shares
Last Trade
Feb 07, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.35M 30,000 shares
$45.00
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $16.4M 569,770 shares
Last Trade
Dec 29, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.44M 30,000 shares
$47.87
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $17.2M 599,743 shares
Last Trade
Oct 19, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.6M 47,853 shares
$33.52
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $0 0 shares
Last Trade
Oct 19, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.6M 47,853 shares
$33.45
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $18.6M 647,029 shares
Last Trade
Oct 19, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.6M 47,853 shares
$33.45
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
President & CEO
Holding Value $17.2M 599,176 shares
Last Trade
Mar 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$737k 16,140 shares
$45.65
$28.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up